Over the past decade, considerable progress has been made in the control, elimination,
and eradication of neglected tropical diseases (NTDs). Despite these advances, most NTD …

Background: In recent years, a programme of vector control, screening and treatment of
gambiense human African trypanosomiasis (gHAT) infections led to a rapid decline in cases in …

Background Human African trypanosomiasis is a parasitic disease caused by trypanosomes
among which Trypanosoma brucei gambiense is responsible for a chronic form (gHAT) in …

Multidrug transporters such as P-glycoprotein require considerable inter-domain communication
to couple energy utilization with substrate translocation. Elucidation of the regions or …

A critical step toward defining tailored therapy in patients with cancer is the identification of
genetic interactions that may impair—or boost—the efficacy of selected therapeutic …

Human African trypanosomiasis, caused by the gambiense subspecies of Trypanosoma
brucei (gHAT), is a deadly parasitic disease transmitted by tsetse. Partners worldwide have …

Gambiense human African trypanosomiasis (gHAT) is a deadly vector-borne, neglected
tropical disease found in West and Central Africa targeted for elimination of transmission (EoT) …

Sleeping sickness (gambiense human African trypanosomiasis, gHAT) is a vector-borne
disease targeted for global elimination of transmission (EoT) by 2030. There are, however, …

Gambiense human African trypanosomiasis (gHAT) is marked for elimination of transmission
(EoT) by 2030. We examined the cost-effectiveness (CE) of EoT in the Democratic Republic …

Understanding the role of single‐nucleotide polymorphisms ( SNP s) in the pathological
process represents a unique experimental challenge especially when the variants occur outside …